Physiology and pathophysiology of iron cardiomyopathy in thalassemia. - Wikidata - awgldk - TriplyDB

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

http://www.wikidata.org/entity/Q33944096

about

Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia MRI Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and Pitfalls Comparison of Doppler echocardiographic and tissue Doppler velocity data in beta-thalassaemia major with high and normal NT-proBNP levels of children in the south-east region of Turkey.Non-transferrin-bound iron (NTBI) uptake by T lymphocytes: evidence for the selective acquisition of oligomeric ferric citrate species.Left ventricular torsional mechanics and myocardial iron load in beta-thalassaemia major: a potential role of titin degradation.R2* imaging of transfusional iron burden at 3T and comparison with 1.5T.Iron overload exacerbates age-associated cardiac hypertrophy in a mouse model of hemochromatosis Magnetic resonance imaging measurement of iron overload.Cardiac iron across different transfusion-dependent diseases.Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron.Iron overload cardiomyopathy: better understanding of an increasing disorder.Cardiac R2* values are independent of the image analysis approach employed.Mechanisms linking red blood cell disorders and cardiovascular diseases Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate Calcium channels and iron uptake into the heart.Magnetic resonance comparison of left-right heart volumetric and functional parameters in thalassemia major and thalassemia intermedia patients.Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia.Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients Estimating tissue iron burden: current status and future prospects.Electrocardiographic consequences of cardiac iron overload in thalassemia major.Longitudinal analysis of heart and liver iron in thalassemia major.Spatial repolarization heterogeneity detected by magnetocardiography correlates with cardiac iron overload and adverse cardiac events in beta-thalassemia major.Cardiac complications in thalassemia major.Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of β-thalassemia.The Correlation between Troponin and Ferritin Serum Levels in the Patients with Major Beta-Thalassemia.Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.Sickle-cell disease and the heart: review of the current literature.Practical medical applications of quantitative MR relaxometry.Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?Establishment of secondary iron overloaded mouse model: evaluation of cardiac function and analysis according to iron concentration.Pulmonary hypertension associated with thalassemia syndromes.Myocardial iron load measured by cardiac magnetic resonance imaging to evaluate cardiac systolic function in thalassemia.Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.Oral nucleic acid therapy using multicompartmental delivery systems.Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha Ceruloplasmin dysfunction: a key factor in the pathophysiology of atrial fibrillation?Assessment of cardiac parameters in evaluation of cardiac functions in patients with thalassemia major.Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels.Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement.Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population.

P2860

Q24186957-27B31CA8-0A05-4CF6-AD14-49CB9DA392CE Q28072173-82D3510E-141F-436A-B925-78E055B92A4C Q31042151-70BB6BA7-098E-40B9-84D1-B8154BF68A55 Q31144456-6E7E1606-555B-403C-BF5A-D53B0575CD42 Q33612314-339DF52C-6721-4A89-8C16-D6D035CE8E26 Q33907529-F48FCEB1-0C6D-486C-A573-77BB952348C5 Q33916265-3D9830ED-E210-47D4-95F8-03A858D7B951 Q33944366-D0C8C780-1778-4804-A95E-EB3418991123 Q33958560-2B08E79E-D189-4C5F-81B3-6F0009695EEF Q34146691-4F27A428-4536-443D-B434-4B7A6E6AE0E3 Q34165921-DE0389D4-6A8C-40A5-8115-8D84D9195673 Q34940609-1669F136-EC9E-4AFE-9A3D-DB8F7D3C7C39 Q35091967-BD85BA27-86D6-4115-A109-F6F93CE834A9 Q35112908-D67711CC-5888-47F8-8DC2-13FF1B65AF1D Q35172888-4F83633D-8CF4-4142-AA7D-948274ED335D Q35438051-0A069DA9-3AE5-483B-AA29-0CC962F7117B Q35644563-7409B5E6-CC45-4FDD-B1E4-9021585A2A62 Q35665822-6FB7B570-F7FD-463A-BC6D-D67912E774B4 Q35793545-CD1D7D20-A2C7-49B7-AFBA-535C5D7187B9 Q35836446-A6F241E2-3D86-4828-A7C8-87879D69E093 Q36915941-18316413-2408-4AD3-AB4D-1CB668E6F4D7 Q37520798-989567C7-9061-4419-B151-B2B06F9AA765 Q37650474-D30AAE90-2C03-4328-9F73-5F946E483F5D Q37668169-FF4F86D5-18DA-4F73-8801-7EE64B7367F7 Q37704006-981446AC-08A0-42A1-B97E-B154490E4C72 Q37833060-FFCB49E9-6C58-4374-ACF7-6F334D6B2E95 Q38005233-19C3AF9B-D0A0-4FCE-A562-E3FC34F859BC Q38044345-BBDA0F5E-36B5-43C7-A856-679A107ACE38 Q38311768-A33EF855-3F18-434A-9634-3E2F6824B874 Q38473461-7E66EDCD-1631-402A-9166-D5DFC1433BEA Q38786355-3DFBD017-3586-4C00-8301-40C197DF200A Q39274361-5DA1F03F-9EDC-427D-A5DA-549BA7BCF7EE Q39300721-870D73A8-E004-4956-8402-1357A79F572D Q39330117-287CC433-98CB-4156-A1DA-A8D1365DCA65 Q42507445-057589F0-C3A3-4F5A-A703-6C1EE9884F8D Q43808703-4548203A-4578-4C28-984B-39C3928A80D2 Q44388142-45526491-ACA9-4542-A588-75F95D7FB448 Q44454875-12AA9134-768C-40B7-9C3B-59DD9C22B4DA Q45132809-860B5373-CEBD-4822-A72D-DBBCACC96CB7 Q48557800-78870315-1937-416B-92BD-87FD80688EF5

P2860

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

http://www.wikidata.org/entity/Q33944096

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

@ast

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

@en

type

label

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

@ast

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

@en

prefLabel

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

@ast

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

@en

P1433

Q33944096-5C00429D-9ED5-4F32-BB31-DA0EA83EEA84

P1476

Q33944096-42206C33-4DC3-48A9-9994-EAE4A66C5201

P2093

Q33944096-710BA76D-1E3E-47C0-9961-3E812889B425

Q33944096-756BC456-5454-413C-89AE-1904BE46F668

Q33944096-7B5F1BDE-DA78-4AD8-8956-DA1058BEEAD0

Q33944096-7CF559CD-C2F4-4B8E-B412-F90D4065FB51

Q33944096-7D037A28-4790-4BEC-A727-693A73B0626B

Q33944096-B3A60783-3523-4122-A66C-5B5BF21D6E6C

Q33944096-D2C103C4-7A9D-4A0A-A760-B952F5F8C52B

Q33944096-EA498CD7-720C-4AA0-A1C9-DCC5BE7661E1

P2860

Q33944096-042905B2-4180-47A3-88E7-82B62863D99C

Q33944096-086D2263-2380-428F-8117-8D92C39D2404

Q33944096-1A801A4D-8BEA-4036-AA2D-83EF959827F2

Q33944096-1F77CC28-A1C5-43B9-AE83-221D83F97AA7

Q33944096-22489912-4C60-4AF5-B54C-DCBDD45923AF

Q33944096-247ED9F9-8451-4425-8627-5C929AA2EF25

Q33944096-27DBDF37-29BB-47D4-85AE-E9206D65C4B0

Q33944096-2980C6FF-4BE2-4557-A8AC-309B9DA1EA04

Q33944096-2D094288-4DB0-468B-BDE8-45246A72CACB

Q33944096-335BE2B6-C61F-4A76-8B1C-8B658543F418

P304

Q33944096-ADA5ABB2-A79C-4ECB-A9F3-714447822169

P31

Q33944096-E0753514-E901-467D-B46B-AF282398E4C8

P356

Q33944096-8D151188-FF7A-4D10-BD9A-59DD051E361E

P407

Q33944096-19673D8F-679B-4933-A1A4-9C1974A2457D

P478

Q33944096-FF2DCC49-6F13-4521-917E-8B09461ED662

P577

Q33944096-7B6E4C43-E143-4C52-80C2-9B7598005727

P5875

Q33944096-9BCB16B1-4AF3-48BE-9646-0BBD8878C7B9

P698

Q33944096-562E11A2-CFC8-4462-9741-7227DEFE8145

P921

Q33944096-89A3606C-D0F1-4630-957B-F7F448322F59

P932

Q33944096-2CEB9BF5-54A2-4C08-B990-6813C30F9566

P356

ANNALS.1345.047

P1433

Annals of the New York Academy of Sciences

P1476

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

@en

P2093

Cathleen Enriquez

http://www.w3.org/2001/XMLSchema#string

John C Wood

http://www.w3.org/2001/XMLSchema#string

Marvin D Nelson

http://www.w3.org/2001/XMLSchema#string

Maya Otto-Duessel

http://www.w3.org/2001/XMLSchema#string

Michelle Aguilar

http://www.w3.org/2001/XMLSchema#string

Nilesh Ghugre

http://www.w3.org/2001/XMLSchema#string

Rex Moats

http://www.w3.org/2001/XMLSchema#string

Thomas D Coates

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular basis of triggered arrhythmias in heart failure

Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

Iron-chelating therapy and the treatment of thalassemia.

Mouse models of mitochondrial dysfunction and heart failure.

Ultrastructural pathology of iron-loaded rat myocardial cells in culture.

Management of cardiac complications in patients with thalassemia major.

Mimicking liver iron overload using liposomal ferritin preparations

The effects of cardiac myocytes on interstitial fibroblasts in toxic iron overload.

Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool.

P304

386-395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1196/ANNALS.1345.047

http://www.w3.org/2001/XMLSchema#string

P407

P478

1054

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7429491

http://www.w3.org/2001/XMLSchema#string

P698

16339687

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

2892916

http://www.w3.org/2001/XMLSchema#string